Crossmark

RAS pathway mutations as a predictive biomarker for treatment adaptation in pediatric B-cell precursor acute lymphoblastic leukemia

Crossref DOI link: https://doi.org/10.1038/leu.2017.303

Published Online: 2017-10-03

Published Print: 2018-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Jerchel, I S

Hoogkamer, A Q

Ariës, I M

Steeghs, E M P

Boer, J M

Besselink, N J M

Boeree, A

van de Ven, C

de Groot-Kruseman, H A

de Haas, V

Horstmann, M A

Escherich, G

Zwaan, C M

Cuppen, E

Koudijs, M J

Pieters, R

den Boer, M L
License Information

Text and Data Mining valid from 2017-10-03
More Information

Article History

Received: 5 December 2016

Revised: 31 August 2017

Accepted: 20 September 2017

First Online: 3 October 2017

Competing interests

: The authors declare no conflict of interest.